File photo: Jim Watson of AFP/Getty Images
The funding will be used to develop Affinivax’s Multiple Antigen Presenting System (MAPS) technology platform and enable the development of vaccines to protect children and adults in the developed and developing worlds, with an initial focus on Streptococcus pneumoniae.
“It is unacceptable that pneumonia remains the leading cause of death among children under 5,” said Trevor Mundel, president of the global health unit at the Gates Foundation.
The company has also secured an exclusive license from Boston Children’s Hospital for intellectual property related to MAPS. The platform was initially developed at Children’s by Dr. Richard Malley, Affinivax’s scientific founder.
Bill Gates has backed Boston-area companies before. One of his investments was in Foundation Medicine, a Cambridge company that specializes in genomic testing for cancer patients.
Bill Gates is the cofounder and former chief executive of Microsoft Corp.
The South Boston Waterfront may hog the limelight these days. But city officials are turning their attention to Charlestown’s historic Navy Yard, where nearly 2,000 people live.Continue reading »
French drug maker plans to move 2,700 employees into 900,000 square feet at new development.Continue reading »
The university’s information and sciences college will be named after the donor, Amin Khoury.Continue reading »
Federal Reserve expected to hike interest rates Wednesday, a move Trump calls ‘foolish’ and ‘incredible’Continue reading »
The story provides a fly-on-the-wall view of events that Boston readers could never have expected when General Electric moved to Fort Point Channel in the summer of 2016.Continue reading »
Jon Harrington found out the hard way that sometimes the sites rely on smaller, less reliable agencies to do the booking.Continue reading »
A demonstration in Boston was the latest in a series of actions across the country denouncing reductions in Amtrak meal service and the job losses that could ensue.Continue reading »
US stocks skidded Monday as another day of big losses took the market to its lowest level in more than a year.Continue reading »
The company said its former chief executive tried to hide evidence as he made a frenzied attempt to save his legacy and reap a lucrative severance.Continue reading »